D-0297-2021 Class II Terminated
FDA drug recall D-0297-2021 was initiated by Teva Pharmaceuticals USA on Feb 15, 2021 and is designated Class II. Reason for recall: Chemical contamination; Unknown brown residue adhering to the inside of one vial. The recall status is terminated (terminated Aug 26, 2021). Affected quantity: 9,452 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 10, 2021
- Initiation Date
- Feb 15, 2021
- Termination Date
- Aug 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,452 cartons
Product description
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
Reason for recall
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Distribution pattern
Nationwide, including Puerto Rico
Code information
Lot # 31325335B, exp. date 07/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0297-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026